Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,072,597
+$2,072,597 QoQ
Shares Held
55,700
Ownership
0.071%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#101
of 252 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Derivatives in CLDX
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$3,348,900
PutShares
90,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. CLDX ranks #26 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in CLDX
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,348,900 | 90,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $2,072,597 | 55,700 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $461,010 | 25,400 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $188,564 | 7,462 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $9,425,710 | 373,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $3,738,900 | 110,000 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $849,750 | 25,000 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $11,896,500 | 350,000 | Call | Sole | 2024-11-14 | |
| 2024-03-31 | $3,357,600 | 80,000 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $6,984,126 | 176,100 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $1,574,502 | 39,700 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $4,560,900 | 115,000 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $2,752,000 | 100,000 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $357,760 | 13,000 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $5,504,000 | 200,000 | Call | Sole | 2023-11-14 | |
| 2023-03-31 | $3,936,212 | 109,400 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $8,775,833 | 196,900 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $222,850 | 5,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,534,859 | 196,900 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $307,635 | 10,944 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $27,512,680 | 1,020,500 | Call | Sole | 2022-08-15 | |
| 2022-06-30 | $4,076,352 | 151,200 | Put | Sole | 2022-08-15 | |
| 2022-03-31 | $17,207,112 | 505,200 | Call | Sole | 2022-05-13 | |
| 2021-12-31 | $1,023,960 | 26,500 | Shares | Sole | 2022-02-11 | |
| 2021-12-31 | $19,482,288 | 504,200 | Call | Sole | 2022-02-11 | |
| 2021-09-30 | $3,941,270 | 73,000 | Shares | Sole | 2021-11-12 | |
| 2021-09-30 | $8,638,400 | 160,000 | Call | Sole | 2021-11-12 | |
| 2021-06-30 | $3,805,472 | 113,800 | Put | Sole | 2021-08-16 | |
| 2020-12-31 | $1,759,008 | 100,400 | Call | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||